Previous studies of patients with systemic lupus erythematosus (SLE) have shown an increased frequency of certain major histocompatibility complex (MHC) markers, including HLA-DR2, DR3, and C4AQO (CIA-null), -in Caucasian patients. However, most of these studies were of randomly selected, unrelated patients; families were not included, and haplotypes were not determined. In order to define more accurately the possible role of MHC genes in lupus susceptibility, HLA-A, B, C, and DR, as well as BF, C2, C4A, C4B, and GLO, markers were determined in 62 Caucasian patients of known ethnic background, and in the members of their families. The distributions of extended haplotypes (fixed combinations of HLA-B, DR, and complotype alleles), fragments thereof, and individual alleles were determined in SLE patients and controls. The MHC distributions in all patients were compared with haplotypes in a normal Caucasian population. There were no statistically significant differences between the frequencies of any MHC marker, fragment, or extended haplotype in the patients compared with the controls. The notion that genetic factors play a role in susceptibility to systemic lupus erythematosus (SLE) is based on the following observations: 1) there is a high rate of concordance for disease in monozygotic twins (14); 2) SLE and its immunologic abnormalities are found with increased frequency in relatives of SLE patients (5-11); 3) SLE is found more commonly in certain ethnic groups (12.13); and 4) a number of genetic markers have been found more frequently among SLE patients than in the general population. These genetic markers include the Gm phenotype 1.3.17:5.13.21 (14-16) and, according to some observers, low levels of erythrocyte CRl (17.18).